drugset / Trial / NCT06955390
Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to observe and evaluate the efficacy and safety of HRS-4642 combined with SHR-A2102 in the treatment of advanced solid tumors
Timeline
- Start
- 2025-05-01
- Primary completion
- 2025-12-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-4642 | Unknown | — | — |
| Subject | SHR-A2102 | Other / unclassified | — | — |